Skip to content

Clinical study to confirm anti-sarcopenia effect of test food.

Clinical study to confirm anti-sarcopenia effect of test food. - Clinical study to confirm anti-sarcopenia effect of test food.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050152
Enrollment
50
Registered
2023-01-30
Start date
2023-01-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Ingestion of test food containing functional substance for 12 weeks Ingestion of placebo for 12 weeks

Sponsors

EP Mediate Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy males and females aged 40 and over who are aware of a decline in muscle strength due to aging (2) Subjects with a score of 1.1 or more and less than 1.3 in two-step test conducted in the screening examination (3) Subjects who can understand the purpose and content of this study and voluntarily agree to participate in this study

Exclusion criteria

Exclusion criteria: Subjects (1) who have or have a history of any disease that may affect the evaluation of the study (2) who have difficulty in daily activities or walking due to severe pain, or who are unable to perform exercise training (3) diagnosed with sarcopenia (4) who have a possibility of recurrence of locomotory disease due to exercise training (5) who regularly use health foods that may affect the evaluation of the study (6) who regularly use pharmaceuticals (7) who exercise regularly (8) who exercise excessively (9) with a history of locomotory disease within 1 year before the screening examination (10) who use canes or supporters (11) who periodically conduct actions that may affect the evaluation of effectiveness (12) who are under treatment of diseases on the joints (13) who have or have a history of severe diseases (14) who are under treatment or have a history of mental diseases (15) who have unsteady lifestyle or who work manual labor (16) who drink a lot (17) who have possibilities for emerging allergy onset related to the study (18) who are judged as unsuitable for the study based on the results of screening examination (19) who have participated in other clinical study within a month before the screening test or who intend to participate in the study period (20) who are in a pregnancy or lactation period in the study period (21) who are judged as unsuitable due to lifestyle questionnaire (22) who cannot carry out the test as instructed (23) who are judged as unsuitable for the study by investigator for other reasons

Design outcomes

Primary

MeasureTime frame
Soft lean mass Body fat mass

Secondary

MeasureTime frame
Timed Up & Go Test Grip strength Knee extension strength Growth hormone Falls efficacy scale

Countries

Japan

Contacts

Public ContactMariko Kondo

EP Mediate Co., Ltd. Foods Department, Trial Planning Section 2

kondo.mariko793@eps.co.jp070-3023-8211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026